ASARINA PHARMA

Asarina Pharma AB is a Swedish biotech company focusing on the development of Sepranolone (UC1010) for the treatment of premenstrual dysphoric disorder and other menstrually related conditions. The company's primary goal is to offer a novel therapy that is specifically designed for PMDD. Asarina has a second generation oral compound in preclinical development for PMDD
ASARINA PHARMA
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.asarinapharma.com
Total Employee:
1+
Status:
Active
Contact:
+46 8 524 844 84
Total Funding:
24.83 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Current Employees Featured
Peter Nordkild Chief Executive Officer @ Asarina Pharma
Chief Executive Officer
2016-01-01
Torbjorn Backstrom Owner @ Asarina Pharma
Owner
2006-01-01
Mรคrta Segerdahl Chief Medical Officer @ Asarina Pharma
Chief Medical Officer
2018-08-01
Founder
Stock Details
Investors List
Rosetta Capital
Rosetta Capital investment in Post-IPO Equity - Asarina Pharma
Kurma Partners
Kurma Partners investment in Post-IPO Equity - Asarina Pharma
Idinvest Partners
Idinvest Partners investment in Post-IPO Equity - Asarina Pharma
Idinvest Partners
Idinvest Partners investment in Venture Round - Asarina Pharma
Kurma Partners
Kurma Partners investment in Venture Round - Asarina Pharma
Rosetta Capital
Rosetta Capital investment in Venture Round - Asarina Pharma
Karolinska
Karolinska investment in Venture Round - Asarina Pharma
Kurma Partners
Kurma Partners investment in Venture Round - Asarina Pharma
Official Site Inspections
http://www.asarinapharma.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: linux1.curanet.dk
- IP address: 94.231.106.219
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
